Medinol

🌟 News from INDIA LIVE 2025! 🌟 Our Sales and Marketing Executive, Uri Fligil, presented Medinol's innovative EluNIR-PERL DES at the prestigious INDIA LIVE 2025 Cardiology Conference. This groundbreaking event marked the beginning of our collaboration with Translumina Therapeutics, who will be distributing EluNIR-PERL DES in India. Uri's presentation highlighted the advanced features and benefits of EluNIR-PERL DES, reinforcing Medinol's commitment to delivering cutting-edge cardiovascular solutions. We are confident that this partnership will significantly enhance patient care in India. Stay tuned for more updates as we continue to make strides in the field of cardiology! 💙

🚀 Join Our Team as a Process Engineer! 🚀 Are you passionate about optimizing processes and driving efficiency? We're looking for a talented Process Engineer to join our team! 🔧 Role: Process Engineer 📍 Location: Har Hotzvim, Jerusalem 💼 Type: Full-time Apply now: [email protected]

🌟 Celebrating Another Achievement! 🌟 We are thrilled to announce yet another successful implantation of the ChampioNIR Drug-Eluting Peripheral Stent, expertly performed by Dr. Femi Oshin and the dedicated team at Royal Perth Hospital East Metropolitan Health Service. The CHAMPIONSHIP First In Human study aims to enroll 30 patients across 7 sites in Australia and the United States, marking a significant step forward in medical innovation. The ChampioNIR stent system is a game-changer in peripheral stenting, featuring a unique design that combines a metallic component for radial support with a bioresorbable polymeric mesh for longitudinal flexibility. This ensures both durability and adaptability in complex anatomical regions. A huge shoutout to everyone involved for their unwavering commitment and expertise in enhancing patient care! 👏 #MedicalInnovation #Healthcare #ChampioNIR #PatientCare #Teamwork #Success #SFA #peripheralstent

#THT2025 The Countdown Begins! THT kicks off on Tuesday, February 11, in Boston! Join us for these exciting sessions: Tuesday, Feb 11 - 4:37 PM: Microtech, Lecturer Dr. Yoram Richter, Medinol CEO Thursday, Feb 13 - 9:06 AM: First In Human Use of the Microtech Pressure Sensor, Lecturer Dr. Yoram Richter, Medinol CEO We can't wait to see you there!

🌟 Exciting News! 🌟 We are thrilled to announce that Medinol will be attending the THT Conference in Boston! Join us for two insightful sessions: 📅 Tuesday, February 11, 3:15 PM — 5:00 PM EST The Future of Remote Patient Monitoring (RPM) 📍 Room: Ensemble C-D | Level 2 | Omni Boston Hotel at the Seaport 🕗 4:37 PM  📌 "Microtech" 🎤 Lecturer: Dr. Yoram Richter, Medinol CEO 📅 Thursday, February 13, 8:00 AM — 9:28 AM EST  📍 Room: Ensemble E-F | Level 2 | Omni Boston Hotel at the seaport 🕗 9:17 AM 📌 "First In Human Use of The Microtech Pressure Sensor" 🎤 Lecturer: Dr. Yoram Richter, Medinol CEO Don't miss this opportunity to learn about the future of remote patient monitoring and the First In Human of the Microtech Pressure Sensor. We look forward to connecting with industry leaders and sharing our progress. #THTConference #HealthcareInnovation #RemotePatientMonitoring #Microtech #THT2025

🌟 Exciting News from Microtech! 🌟 We are proud to announce a groundbreaking milestone in heart failure treatment. Microtech, a wholly owned subsidiary of Medinol, has successfully completed the First Human Case of Implantable Microsensor for Heart Failure.   The first implantation was performed by Prof. Erez Sharoni, Head of Cardio-Thoracic Surgery, at Beilinson Medical Center in Israel. This technology promises to revolutionize the standard of care for heart failure patients, offering earlier intervention and reducing hospitalizations. Stay tuned as we continue to innovate and improve healthcare for patients worldwide. 🌍💙 https://lnkd.in/dj_iU_vT #MedTech #Innovation #HeartFailure #Healthcare #Medinol

🎉 We are thrilled to announce a groundbreaking achievement at Beilinson Hospital for our Microtech Implantable Microsensor Platform! 🎉 For the first time, the Microtech Implantable Microsensor, has been successfully implanted. The first implantation was performed by Prof. Erez Sharoni at Beilinson Medical Center in Petah-Tikva, Israel. Dr. Tuvia Ben-Gal, Director of the Heart Failure Unit, highlights the limitless potential of this innovation in cardiac care: "The sky is the limit given that the sensor is so small and can be attached to any device we implant in the heart. The ease and reliability with which the signal is obtained from it allows for a breakthrough in monitoring and treating cardiac patients in general - not just those suffering from heart failure." December 24, 2024, Ynet 🫶 Kudos to the esteemed Beilinson team for their dedication and expertise. This milestone represents a substantial advancement in the monitoring and treatment of cardiac patients. To read more in Hebrew: https://lnkd.in/dDHnpFUC #Innovation #Healthcare #Cardiology #BeilinsonHospital

💫 Happy Holidays and a Happy New Year! 💫 As we wrap up 2024, we want to extend our heartfelt gratitude to our amazing partners, team members, friends, and family. Your support and dedication have been the driving force behind our success. May this holiday season bring you joy, peace, and cherished moments with loved ones. Here's to a prosperous and exciting 2025 filled with new opportunities and achievements!

 🎉 We are excited to share the latest findings from the 5‐Year Outcomes from the BIONICS and NIREUS Trials, showcasing the EluNIR Ridaforolimus-Eluting Stent System's outstanding clinical benefits.   Long-Term Safety and Efficacy: Proven performance over 5 years with low rates of stent thrombosis and target lesion failure. Controlled Drug Elution: Innovative elastic polymer ensures consistent and controlled release of ridaforolimus. Rapid Vessel Healing: Unique dual-pattern strut design promotes quick and effective vessel healing post-PCI. Comparable Performance: Demonstrated similar outcomes to other leading stents, supporting its use in coronary artery disease treatment.   These results underscore our commitment to advancing cardiovascular care and improving patient outcomes.   Read more about our research: https://lnkd.in/dYfs68_z      

Join Our Team! 🌟Medinol is Hiring a Head of Regulatory Affairs 🌟 Are you a seasoned professional in Regulatory Affairs with a passion for innovation in the medical device industry? Medinol is seeking a dynamic and experienced Head of Regulatory Affairs to lead our regulatory strategy and ensure compliance with global standards. https://lnkd.in/dQuKgVg4